Beppu Yoko, Asada Akira, Morishima Kuniko, Kurita Satoshi, Nakatani Keiji
Department of Anesthesiology, Osaka Koseinenkin Hospital, Osaka 553-0003.
Masui. 2013 Apr;62(4):426-30.
Intravenous patient-controlled analgesia (iv-PCA) has a great advantage for pain control in the postoperative period with occasional disadvantages of postoperative nausea and vomiting, which should be treated appropriately. Droperidol is commonly used as anti-emetic drug, but it also has a potential risk to induce extrapyramidal reactions. We report three patients who showed extrapyramidal reactions among 589 patients after droperidol administration. Although this complication is rare, we should be aware of the possible extrapyramidal reactions due to droperidol.
静脉自控镇痛（iv-PCA）在术后疼痛控制方面具有很大优势，但偶尔会出现术后恶心和呕吐等不良反应，对此应进行适当治疗。氟哌利多通常用作止吐药，但它也有诱发锥体外系反应的潜在风险。我们报告了589例使用氟哌利多的患者中有3例出现锥体外系反应。尽管这种并发症很少见，但我们应该意识到氟哌利多可能导致的锥体外系反应。
